EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Clinical significance of sarcopenia in children with neuroblastic tumors

Wataru Kudo, Keita Terui, Ryoya Furugane, Ayako Takenouchi, Shugo Komatsu, Yunosuke Kawaguchi, Katsuhiro Nishimura, Daisuke Katsumi, Tomoro Hishiki

Pediatric Surgery International · 2024

DOI: 10.1007/s00383-024-05815-9 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Pediatric Surgery International, 2024. Verfasst von Wataru Kudo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan. ccfa4833@chiba-u.jp. Hauptthemen laut MEDLINE: Neuroblastoma, Sarcopenia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To elucidate the clinical significance of sarcopenia in children with neuroblastic tumors (NTs).

Methods

We conducted a retrospective observational study and analyzed the z-scores for height, body weight, body mass index, and skeletal muscle index (HT-z, BW-z, BMI-z, and SMI-z) along with the clinical characteristics of 36 children with NTs. SMI-z was calculated from 138 computed tomography scans at diagnosis, during treatment, and at follow-up. The International Neuroblastoma Risk Group classification was used to identify high-risk groups. We analyzed the data at diagnosis for prognostic analysis and changes over time after diagnosis in the HT-z, BW-z, BMI-z, and SMI-z groups.

Results

Among the four parameters at diagnosis, only SMI-z predicted overall survival (hazard ratio, 0.58; 95% confidence interval, 0.34–0.99). SMI-z, HT-z, and BW-z significantly decreased over time after diagnosis ( P < 0.05), while BMI-z did not ( P = 0.11). In surviving high-risk NT cases without disease, SMI-z, HT-z, and BW-z significantly decreased over time ( P < 0.05), while BMI-z did not ( P = 0.43).

Conclusion

In children with NT, the SMI-z at diagnosis was a significant prognostic factor and decreased during treatment and follow-up along with HT-z and BW-z. Monitoring muscle mass is important because sarcopenia may be associated with growth impairment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaSarcopeniaChildChild, PreschoolFemaleHumansInfantMaleBody Mass IndexClinical RelevanceFollow-Up StudiesPrognosisRetrospective StudiesTomography, X-Ray Computed

Stichwörter der Autor:innen

Growth impairmentNeuroblastic tumorSarcopeniaSkeletal muscle index

Autor:innen und Institutionen

  • Department of Pediatric Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan. ccfa4833@chiba-u.jp.
  • Division of Pediatric Surgery, Department of Surgery, Graduate School of Medicine, Jichi Medical University, Shimotsuke, Japan.
  • Department of Pediatric Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.

Zitieren

APA

Kudo, W., Terui, K., Furugane, R., Takenouchi, A., Komatsu, S., Kawaguchi, Y., Nishimura, K., Katsumi, D., & Hishiki, T. (2024). Clinical significance of sarcopenia in children with neuroblastic tumors. Pediatric Surgery International. https://doi.org/10.1007/s00383-024-05815-9

Vancouver

Kudo W, Terui K, Furugane R, Takenouchi A, Komatsu S, Kawaguchi Y, et al. Clinical significance of sarcopenia in children with neuroblastic tumors. Pediatric Surgery International. 2024. doi:10.1007/s00383-024-05815-9

BibTeX
@article{Kudo2024,
  author = {Kudo, Wataru and Terui, Keita and Furugane, Ryoya and Takenouchi, Ayako and Komatsu, Shugo and Kawaguchi, Yunosuke and Nishimura, Katsuhiro and Katsumi, Daisuke and Hishiki, Tomoro},
  title = {Clinical significance of sarcopenia in children with neuroblastic tumors},
  journal = {Pediatric Surgery International},
  year = {2024},
  doi = {10.1007/s00383-024-05815-9}
}
Kostenlos starten →